LCS
AMAG

Levin Capital Strategies’s AMAG Pharmaceuticals AMAG Stock Holding History

Levin Capital Strategies’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-64,825
Closed -$1.25M – 376
2014
Q1 		$1.25M Buy
+64,825
New +$1.38M 0.02% 201

Other funds holding AMAG

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Levin Capital Strategies's AMAG Position: Q2 2014 in Review

Levin Capital Strategies sold out of AMAG Pharmaceuticals (AMAG) in Q2 2014, closing a stake of 64,825 shares — an estimated $1.25M sold.

Levin Capital Strategies first reported a position in AMAG in Q1 2014 and held it in 1 quarter. The position peaked at $1.25M in Q1 2014. 100 funds tracked by Wall St. Rank hold AMAG as of Q2 2014.

  • Levin Capital Strategies reported no remaining AMAG Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
  • Levin Capital Strategies sold 64,825 AMAG Pharmaceuticals shares in Q2 2014, an estimated $1.25M.
  • Levin Capital Strategies first reported a position in AMAG Pharmaceuticals in Q1 2014 and held it in 1 quarter.
  • Levin Capital Strategies's AMAG Pharmaceuticals position peaked at $1.25M in Q1 2014.
  • 100 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2014.

Based on Levin Capital Strategies's 13F filing for Q2 2014, filed 13 Aug 2014.